Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre L Triozzi

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 3, 2018
Practical Guidelines for Cerenkov Luminescence Imaging with Clinically Relevant IsotopesNikunj B Bhatt, Darpan N Pandya, William A Dezarn, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2004
Enhanced gene transfer to mouse dendritic cells using adenoviral vectors coated with a novel adapter moleculeAlexander V Pereboev, Jill M Nagle, Mikhail A Shakhmatov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2013
Phase I dose-escalation study of VB-111, an antiangiogenic virotherapy, in patients with advanced solid tumorsAndrew J Brenner, Yael C Cohen, Eyal Breitbart, et al.
Oncology Letters|January 19, 2019
Circulating immune biomarkers as predictors of the response to pembrolizumab and weekly low dose carboplatin and paclitaxel in NSCLC and poor PS: An interim analysisMarcelo Bonomi, Tamjeed Ahmed, Safoa Addo, et al.
Human Gene Therapy|February 11, 2005
Intratumoral administration of a recombinant canarypox virus expressing interleukin 12 in patients with metastatic melanomaPierre L Triozzi, Theresa V Strong, R Pat Bucy, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 30, 2007
Anti-GD3 monoclonal antibody effects on lymphocytes and antibody-dependent cellular cytotoxicityPierre L Triozzi, Jatin J Shah, Wen-Quan Wang, et al.
Investigative Ophthalmology & Visual Science|April 19, 2012
Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism arrayArun D Singh, Mary E Aronow, Yang Sun, et al.
Human Gene Therapy|September 9, 2004
Augmentation of antitumor activity of a recombinant adeno-associated virus carcinoembryonic antigen vaccine with plasmid adjuvantSelvarangan Ponnazhagan, Gandham Mahendra, Jose Lima, et al.
Journal of Virology|October 15, 2003
Genetically targeted adenovirus vector directed to CD40-expressing cellsNatalya Belousova, Nikolay Korokhov, Valentina Krendelshchikova, et al.
Cancer Research Communications|February 12, 2024
Low-dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic Responses in Platinum-refractory Urothelial CarcinomaRhonda L Bitting, Janet A Tooze, Michael Goodman, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Methods in Molecular Biology (Clifton, N.J.)|June 3, 2018
Practical Guidelines for Cerenkov Luminescence Imaging with Clinically Relevant IsotopesNikunj B Bhatt, Darpan N Pandya, William A Dezarn, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2004
Enhanced gene transfer to mouse dendritic cells using adenoviral vectors coated with a novel adapter moleculeAlexander V Pereboev, Jill M Nagle, Mikhail A Shakhmatov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2013
Phase I dose-escalation study of VB-111, an antiangiogenic virotherapy, in patients with advanced solid tumorsAndrew J Brenner, Yael C Cohen, Eyal Breitbart, et al.
Oncology Letters|January 19, 2019
Circulating immune biomarkers as predictors of the response to pembrolizumab and weekly low dose carboplatin and paclitaxel in NSCLC and poor PS: An interim analysisMarcelo Bonomi, Tamjeed Ahmed, Safoa Addo, et al.
Human Gene Therapy|February 11, 2005
Intratumoral administration of a recombinant canarypox virus expressing interleukin 12 in patients with metastatic melanomaPierre L Triozzi, Theresa V Strong, R Pat Bucy, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 30, 2007
Anti-GD3 monoclonal antibody effects on lymphocytes and antibody-dependent cellular cytotoxicityPierre L Triozzi, Jatin J Shah, Wen-Quan Wang, et al.
Investigative Ophthalmology & Visual Science|April 19, 2012
Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism arrayArun D Singh, Mary E Aronow, Yang Sun, et al.
Human Gene Therapy|September 9, 2004
Augmentation of antitumor activity of a recombinant adeno-associated virus carcinoembryonic antigen vaccine with plasmid adjuvantSelvarangan Ponnazhagan, Gandham Mahendra, Jose Lima, et al.
Journal of Virology|October 15, 2003
Genetically targeted adenovirus vector directed to CD40-expressing cellsNatalya Belousova, Nikolay Korokhov, Valentina Krendelshchikova, et al.
Cancer Research Communications|February 12, 2024
Low-dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic Responses in Platinum-refractory Urothelial CarcinomaRhonda L Bitting, Janet A Tooze, Michael Goodman, et al.
Pageof 6